Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-22 Bancel Stephane Chief Executive Officer Exercise or conversion +40,000 $0.99 $40K 5,451,946
2023-02-22 Bancel Stephane Chief Executive Officer Sale −10,472 $157.87 $1.7M 5,441,474
2023-02-22 Bancel Stephane Chief Executive Officer Sale −20,303 $158.53 $3.2M 5,421,171
2023-02-22 Bancel Stephane Chief Executive Officer Sale −8,725 $159.59 $1.4M 5,412,446
2023-02-22 Bancel Stephane Chief Executive Officer Sale −500 $160.28 $80K 5,411,946
2023-02-22 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −40,000 1,427,155
2023-02-22 AFEYAN NOUBAR Director Sale −10,000 $160.35 $1.6M 2,197,209
2023-02-16 Bancel Stephane Chief Executive Officer Exercise or conversion +40,000 $0.99 $40K 5,451,946
2023-02-16 Bancel Stephane Chief Executive Officer Sale −8,952 $172.14 $1.5M 5,442,994
2023-02-16 Bancel Stephane Chief Executive Officer Sale −28,331 $173.30 $4.9M 5,414,663
2023-02-16 Bancel Stephane Chief Executive Officer Sale −2,717 $173.79 $472K 5,411,946
2023-02-16 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −40,000 1,467,155
2023-02-15 Bancel Stephane Chief Executive Officer Exercise or conversion +40,000 $0.99 $40K 5,451,946
2023-02-15 Bancel Stephane Chief Executive Officer Sale −10,327 $173.68 $1.8M 5,441,619
2023-02-15 Bancel Stephane Chief Executive Officer Sale −13,375 $174.77 $2.3M 5,428,244
2023-02-15 Bancel Stephane Chief Executive Officer Sale −14,812 $175.85 $2.6M 5,413,432
2023-02-15 Bancel Stephane Chief Executive Officer Sale −1,486 $176.73 $263K 5,411,946
2023-02-15 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −40,000 1,507,155
2023-02-15 AFEYAN NOUBAR Director Sale −10,000 $173.17 $1.7M 2,207,209
2023-02-10 Hoge Stephen President Sale −245 $163.90 $40K 1,627,693

Page 56 of 66 · 1,314 trades